Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods.
about
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandinFluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of readingIn vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminum oxideCollaborative investigation of variables in susceptibility testing of yeasts.Rapid identification of Candida albicans and other human pathogenic yeasts by using short oligonucleotides in a PCRClinical, cellular, and molecular factors that contribute to antifungal drug resistance.Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis.Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysisComparison of a new colorimetric assay with the NCCLS broth microdilution method (M-27A) for antifungal drug MIC determinationAntifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome.In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative studyEffects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.Epidemiology of nosocomial fungal infections.Antifungal susceptibility tests.Effects of temperature on anti-Candida activities of antifungal antibiotics.Standardized susceptibility testing of fluconazole: an international collaborative study.Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study GroupSusceptibility testing of fungi: current status of the standardization process.Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.Rapid susceptibility testing of fungi by flow cytometry using vital staining.Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media.Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolatesEvaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolatesComparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans.Multicenter evaluation of four methods of yeast inoculum preparation.Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi.Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.Antifungal susceptibility testing: a primer for clinicians.In vitro and in vivo evaluation of antifungal agents.Testing of organisms for susceptibility to triazoles: is it justified?Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.
P2860
Q28316952-B9636466-4E07-4ACB-A464-6A9E34FE97C6Q28326328-DB91BEB0-3C7B-4697-BE41-52E6B20453C3Q28367886-140A5A32-AF7E-4406-BD8E-2B32ED8E8058Q28481546-FEC5C49C-C29F-47BF-ACFE-0D370177B43FQ30451715-6A00D8FE-DF84-43C2-BA96-0026A0D92C27Q33669841-DBE92DE1-2FF9-4A9C-AF71-FF816BCC119AQ33721804-C400E135-F2D7-43E3-973A-C36B0250683AQ33934213-E6C7FAB9-3CD4-4E43-82D0-8EBD11496311Q33935571-3DCF0F7C-3601-4578-8269-0796F946DC78Q33967510-50F551AE-DA0B-43DD-80C4-9D0200D1E641Q33972828-C81E2DF0-A416-4A15-A7C7-AFA244271A24Q34142406-61191B2A-69E5-4518-8F3E-8E11023E6C5FQ35111403-6DE001E8-D548-454B-A7B4-B63F992D2E5BQ35116163-BD5BEE60-77E9-412E-8E7E-76EAE4102BD8Q35128351-B17C17F6-302A-42EE-A471-1C169FF69F64Q35269220-C1C2CC11-E111-41A3-A5F9-6412C4FCA012Q35372424-B259B522-CE7F-45EA-B7A1-AA01678581B6Q35562348-0BCC22A8-3474-4FB4-A0FC-9A4C21A7F8A2Q35811074-FB49AD42-181C-4FE8-9E28-22BAA1BF6CDFQ35896738-2C2E3172-BAAC-48AE-983D-E702BD6CEAE6Q35900191-CBF80EB5-2178-4BB2-9F40-0BF4D07CE853Q35903839-E7C9BB0D-DDD0-48B6-A69B-4632E058C810Q36528018-7CA423F9-927C-4E67-869D-3F316F6CDEC9Q36542368-707FF41F-49BF-4B4F-A759-9F1BD14AF827Q37068914-1E638537-E467-4478-912E-7FAFD12C707FQ37072032-29A419A5-8B1C-4573-85F0-876D2F71388DQ37087471-948BE8FB-C48F-45E3-9DBD-8A3D5BD653CDQ37090580-B0EA7919-48DF-4848-9C26-A0CB5069E6B0Q37094025-B81F5722-6BD0-4BF1-887D-1D77A6399EA8Q37124725-F7DBA2D9-7EB7-4365-B2E1-848CFED9580AQ37152322-1EFD1FA8-4F2F-4D89-962D-C98ECB1A7740Q37230779-29A25C9A-D953-45A5-BBED-17D55F08CB3DQ37235331-54DB7A05-5A85-4087-8712-D7A703F936C1Q37251197-7E813F7E-8973-4CF3-97C5-FC014764A591Q38061087-6F8B5589-D636-41C3-8C56-AD3B0C75BD50Q38223673-EFE2EDD0-8F10-4966-9F8C-EFAC09E753BFQ38281786-1EB68B8C-2889-4A6D-8D4D-81AB03768183Q39474532-A3B27B09-5382-4B1D-A65E-6239E4D37B4BQ39867085-2D921EF9-4202-42E5-A440-C5AA64F4E272Q39881200-9D3A1E14-1BA7-40E1-87C3-1F9401A6DE99
P2860
Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods.
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Comparison of relative suscept ...... ned by unstandardized methods.
@ast
Comparison of relative suscept ...... ned by unstandardized methods.
@en
type
label
Comparison of relative suscept ...... ned by unstandardized methods.
@ast
Comparison of relative suscept ...... ned by unstandardized methods.
@en
prefLabel
Comparison of relative suscept ...... ned by unstandardized methods.
@ast
Comparison of relative suscept ...... ned by unstandardized methods.
@en
P2093
P2860
P356
P1476
Comparison of relative suscept ...... ned by unstandardized methods.
@en
P2093
A Espinel-Ingroff
J N Galgiani
M A Gordon
T M Kerkering
P2860
P304
P356
10.1128/AAC.31.9.1343
P407
P577
1987-09-01T00:00:00Z